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In TIM1 If, 326 pilot and 582 randomized patients (P) 
were on 150 mg. rt-PA and heparin protocole and 6% pilot 
and 2,952 randomized P on 100 mg. &-t-PA and heparin. 
The 100 mg. doee w&e established and P with histories 
of cerebrovascular diseaee excluded because of observed 
rate8 of intracranial hemorrhage. On review of 
computed tomography ecans and clinical data, the 
intracranial hemorthages were classified a8 primary 
intracerebral hemorrhage (IH) cerebral infarction 
with hemorrhagic conversion (CI) and subdural hemorrhage 
(SH) ae follows: 
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Mortality at eix weeks after presentation among 
P who had IN was 47.8 compared to 4.9% for p 
without IH (p c 0.01). XH ie a severe b+ infrequent 
complication of rt-PA therapy for acute myocardial 
infarctLoon. In TIM1 II rick of rt-PA aseociated IH 
was decreased by doee reduction snd patient selection. 
